寻求口服PROTAC药物:评估查管道的弱点
Giulia Apprato1, Giuseppe Ermondi1, Giulia Caron1
1Molecular Biotechnology and Health Sciences Department, University of Torino, Piazza Nizza 44, 10124 Torino, Italy.
ACS medicinal chemistry letters
|July 19, 2023
概括
针对蛋白质溶解向合体 (PROTACs) 的临床前管道存在数据缺口和技术问题. 解决这些缺陷对于提高PROTAC药物开发效率至关重要.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 蛋白质溶解向嵌合体 (PROTACs) 是一种新的治疗方式.
- 临床前开发对于将PROTACs推向临床应用至关重要.
研究的目的:
- 识别和分析当前PROTAC临床前管道中的缺陷.
- 提出建议,以加强PROTAC临床前发展.
主要方法:
- 进行了有针对性的文献搜索.
- 现有的PROTAC临床前数据和方法得到了批判性评估.
主要成果:
- 发现了重大缺陷,包括缺少数据,数据质量差以及实验分析的技术限制.
- 特别强调了实验分析的具体局限性.
结论:
- 目前的PROTAC临床前管道需要大幅改进.
- 实施提出的建议可以提高PROTAC临床前研究的效率和可靠性.
相关概念视频
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K


